GlassScriptPhysician profile
Ryan Charles Roubion
NPI 1154862456
$47,891.12
in general payments reported to CMS, 2019-2025
24 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.79 · 2021: $85.37 · 2022: $32K · 2023: $13K · 2024: $1,116 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $3,210 · Travel and Lodging: $1,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,100.00 |
| Food and Beverage | $3,210.19 |
| Travel and Lodging | $1,979.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,366.13 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Pico 14 |
| Arthrex, INC. | $20,000.00 | 2022 | |
| Stryker Corporation | $5,062.22 | 2022-2025 | Salvation, Mako, Na |
| Alon Medical Technology | $1,248.79 | 2020-2022 | |
| Biorez, INC. | $256.88 | 2022 | |
| Acera Surgical, INC. | $175.64 | 2025 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $148.10 | 2023 | Zynrelef |
| Medacta USA, INC. | $82.82 | 2021-2024 | |
| Virtus Pharmaceuticals LLC | $67.45 | 2024-2025 | Levorphanol Tartrate |
| Avanos Medical | $57.08 | 2025 | On-Q Pump and Accessories |
| Bioventus LLC | $55.66 | 2024 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $51.74 | 2021-2022 | |
| Fidia Pharma USA INC. | $42.54 | 2024 | Hymovis, Triluron, Hyalgan |
| Ferring Pharmaceuticals INC. | $41.39 | 2023-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $41.22 | 2021-2024 | Zilretta, Iovera, Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $28.18 | 2023 | Revomotion |
| Depuy Synthes Sales INC. | $25.15 | 2022 | |
| Nalu Medical, INC. | $24.06 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $23.93 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vericel Corporation | $23.37 | 2024 | Maci |
| Innovation Technologies INC | $23.33 | 2025 | Irrisept |
| Heraeus Medical, LLC. | $21.08 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $14.56 | 2025 | |
| Sonex Health, INC. | $9.80 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Roubion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.